BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies
Technology Anticipated to Impact Cardiac Biologic Therapies, Transseptal Cardiac Procedures, and Other Interventional Catheter Based TherapiesSAN CARLOS, Calif., Oct. 12,...